Entyvio 300Mg C/1 Fa
Vedolizumabe is a selective intestinal immunosuppressant for treating Crohn’s disease and ulcerative colitis. It is administered intravenously in specific dosing schedules.
- The description claims that the safety and efficacy of vedolizumab have not been established in pediatrics.
AI Readiness
Good foundation, but some important product data is still missing.
80%